Winton Capital »

Monopar Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $374k 6.8k 54.79

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Ge Vernova (GEV)
Booking Holdings (BKNG)
Netflix (NFLX)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
CSX Corporation (CSX)
Solstice Advanced Matls Com Shs (SOLS)
Kroger (KR)
AES Corporation (AES)
Entegris (ENTG)
Electronic Arts (EA)
Hologic
Masimo Corporation (MASI)
Stifel Financial (SF)

View all positions for Winton Capital

Top funds holding Monopar Therapeutics

Henderson Group
RA Capital Management
Adage Capital Partners GP
Saturn V Capital Management
Deerfield Management Company
BlackRock
Vanguard Group
ADAR1 Capital Management
Wellington Management Company
Vanguard Capital Management
Siren
Balyasny Asset Management
TCG Crossover Management
Polar Capital Holdings
Alyeska Investment Group

View all funds holding Monopar Therapeutics